Evidence map›Paper›PMID 30442942›Full record

ArticleNature communications2018

Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture.

Silvia Villahoz, Paula Sofía Yunes-Leites, Nerea Méndez-Barbero, Katia Urso, Elena Bonzon-Kulichenko, Sagrario Ortega, J Francisco Nistal, Jesus Vazquez, Stefan Offermanns, Juan Miguel Redondo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Fibronectin-induced overactivation of αNature communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Silvia VillahozGene regulation in cardiovascular remodeling and inflammation group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain.
Paula Sofía Yunes-LeitesGene regulation in cardiovascular remodeling and inflammation group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain.
Nerea Méndez-BarberoGene regulation in cardiovascular remodeling and inflammation group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain.
Katia UrsoGene regulation in cardiovascular remodeling and inflammation group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain.
Elena Bonzon-KulichenkoCentro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.ORCID http://orcid.org/0000-0003-0852-7520
Sagrario OrtegaCentro Nacional de Investigaciones Oncológicas (CNIO), Madrid, 28029, Spain.
J Francisco NistalCentro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.ORCID http://orcid.org/0000-0002-4152-7621
Jesus VazquezCentro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.ORCID http://orcid.org/0000-0003-1461-5092
Stefan OffermannsDepartment of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, 61231, Germany.
Juan Miguel RedondoGene regulation in cardiovascular remodeling and inflammation group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain. jmredondo@cnic.es.ORCID http://orcid.org/0000-0001-5779-9122
Miguel R CampaneroCentro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. mcampanero@iib.uam.es.ORCID http://orcid.org/0000-0003-1410-8621
Spanish National Centre for Cardiovascular Research · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESMax Planck Institute for Heart and Lung Research · DESpanish National Cancer Research Centre · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic intramural hematoma (IMH) can evolve toward reabsorption, dissection or aneurysm. Hypertension is the most common predisposing factor in IMH and aneurysm patients, and the hypertensive mediator angiotensin-II induces both in mice. We have previously shown that constitutive deletion of Rcan1 isoforms prevents Angiotensin II-induced aneurysm in mice. Here we generate mice conditionally lacking each isoform or all isoforms in vascular smooth muscle cells, endothelial cells, or ubiquitously, to determine the contribution to aneurysm development of Rcan1 isoforms in vascular cells. Surprisingly, conditional Rcan1 deletion in either vascular cell-type induces a hypercontractile phenotype and aortic medial layer disorganization, predisposing to hypertension-mediated aortic rupture, IMH, and aneurysm. These processes are blocked by ROCK inhibition. We find that Rcan1 associates with GSK-3β, whose inhibition decreases myosin activation. Our results identify potential therapeutic targets for intervention in IMH and aneurysm and call for caution when interpreting phenotypes of constitutively and inducibly deficient mice.

Indexed as

AnimalsAntihypertensive AgentsAortaAortic DissectionAortic RuptureCalcium-Binding ProteinsDisease Models, AnimalEndothelial CellsGene DeletionGene Expression RegulationGenetic Predisposition to DiseaseGlycogen Synthase Kinase 3 betaHematomaHumansHypertensionIntracellular Signaling Peptides and ProteinsAntihypertensive AgentsCalcium-Binding ProteinsDSCR1 protein, mouseGlycogen Synthase Kinase 3 betaIntracellular Signaling Peptides and ProteinsMuscle ProteinsProtein IsoformsProtein Kinase Inhibitorsrho-Associated Kinases

Identifiers

PMID30442942
PMCPMC6237779
OpenAlexW2899665377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.